EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review

Qasem Al-Tashi iD, Maliazurina B Saad, Amgad Muneer iD, Rizwan Qureshi, Seyedali Mirjalili iD, Ajay Sheshadri, Xiuning Le, Natalie I Vokes iD, Jianjun Zhang iD, Jia Wu iD

International Journal of Molecular Sciences · 24.04.2023 · 24 (9) · 7781

DOI: 10.3390/ijms24097781 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.04.2023. Verfasst von Qasem Al-Tashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, the generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Lung Moon Shot Program, the National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The identification of biomarkers plays a crucial role in personalized medicine, both in the clinical and research settings. However, the contrast between predictive and prognostic biomarkers can be challenging due to the overlap between the two. A prognostic biomarker predicts the future outcome of cancer, regardless of treatment, and a predictive biomarker predicts the effectiveness of a therapeutic intervention. Misclassifying a prognostic biomarker as predictive (or vice versa) can have serious financial and personal consequences for patients. To address this issue, various statistical and machine learning approaches have been developed. The aim of this study is to present an in-depth analysis of recent advancements, trends, challenges, and future prospects in biomarker identification. A systematic search was conducted using PubMed to identify relevant studies published between 2017 and 2023. The selected studies were analyzed to better understand the concept of biomarker identification, evaluate machine learning methods, assess the level of research activity, and highlight the application of these methods in cancer research and treatment. Furthermore, existing obstacles and concerns are discussed to identify prospective research areas. We believe that this review will serve as a valuable resource for researchers, providing insights into the methods and approaches used in biomarker discovery and identifying future research opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeoplasmsHumansPrognosisProspective StudiesBiomarkersPrecision MedicineMachine Learning

Stichwörter der Autor:innen

biomarker discoverydeep learningfeature selectionmachine learningpersonalized medicinepredictive biomarkerprognostic biomarkersubgroup identification

Substanzen

Biomarkers, TumorBiomarkers

Autor:innen und Institutionen

  • Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Centre for Artificial Intelligence Research and Optimization, Torrens University Australia, Fortitude Valley, Brisbane, QLD 4006, Australia.
  • Yonsei Frontier Lab, Yonsei University, Seoul 03722, Republic of Korea.
  • University Research and Innovation Center, Obuda University, 1034 Budapest, Hungary.
  • Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Qasem Al-Tashi, Amgad Muneer, Seyedali Mirjalili, Natalie I Vokes, Jianjun Zhang, Jia Wu

Förderung

  • NCI NIH HHS
  • the generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Lung Moon Shot Program
  • the National Institutes of Health (NIH)
  • generous philanthropic contributions from Mrs. Andrea Mugnaini and Dr. Edward L. C. Smith
  • Rexanna’s Foundation for Fighting Lung Cancer
  • Damon Runyon Mark Foundation Physician-Scientist Award
  • MD Anderson Bridge Funds

Zitieren

APA

Al-Tashi, Q., Saad, M. B., Muneer, A., Qureshi, R., Mirjalili, S., Sheshadri, A., Le, X., Vokes, N. I., Zhang, J., & Wu, J. (2023). Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. International Journal of Molecular Sciences, 24(9), 7781. https://doi.org/10.3390/ijms24097781

Vancouver

Al-Tashi Q, Saad MB, Muneer A, Qureshi R, Mirjalili S, Sheshadri A, et al. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. International Journal of Molecular Sciences. 2023;24(9):7781. doi:10.3390/ijms24097781

BibTeX
@article{AlTashi2023,
  author = {Al-Tashi, Qasem and Saad, Maliazurina B and Muneer, Amgad and Qureshi, Rizwan and Mirjalili, Seyedali and Sheshadri, Ajay and Le, Xiuning and Vokes, Natalie I and Zhang, Jianjun and Wu, Jia},
  title = {Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {7781},
  doi = {10.3390/ijms24097781}
}
Kostenlos starten →